Skip to main content

Animations

MJFF Publications

6981 - 6990 of 8620 Results
Title
Year
  • Year
  • 2021
  • 2018
  • 2021
  • 2008
  • 2025
  • 2025
  • 2021
  • 2012
  • 2023
  • 2021
  • Summary Details
    OPEN
    Title: Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01233-3
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.007
    Citation Count: 121
  • Summary Details
    OPEN
    Title: T lymphocyte senescence is attenuated in Parkinson’s disease
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-021-02287-9
    Citation Count: 31
  • Summary Details
    RESTRICTED
    Title: The Unified Dyskinesia Rating Scale: Presentation and clinimetric profile
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.22341
    Best OA location URL:
    Citation Count: 231
  • Summary Details
    OPEN
    Title: Genome-Wide Association Study of Glucocerebrosidase Activity Modifiers
    Journal Name: Molecular Neurobiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s12035-025-04996-1
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Carrying on a Father's Legacy
    Journal Name: Brain & Life
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/01.nnn.0001125860.72537.e7
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Updating MISEV: Evolving the minimal requirements for studies of extracellular vesicles
    Journal Name: Journal of Extracellular Vesicles
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/jev2.12182
    Citation Count: 263
  • Summary Details
    OPEN
    Title: GSK2578215A; A potent and highly selective 2-arylmethyloxy-5-substitutent-N-arylbenzamide LRRK2 kinase inhibitor
    Journal Name: Bioorganic & Medicinal Chemistry Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bmcl.2012.06.104
    Citation Count: 143
  • Summary Details
    OPEN
    Title: Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-023-01563-4
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Sex- and age‐dependent alterations of splenic immune cell profile and NK cell phenotypes and function in C57BL/6J mice
    Journal Name: Immunity & Ageing
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12979-021-00214-3
    Citation Count: 61
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.